NP-1815-PX
NP-1815-PX is a potent and selective P2X4R antagonist. NP-1815-PX has anti-inflammatory activity, and can relieve pain in chronic pain models. NP-1815-PX also inhibits guinea pig tracheal/bronchial smooth muscle (TSM and BSM) contractions[1][2][3].
Product Specifications
CAS Number
1239578-79-0
UNSPSC
12352005
Target
P2X Receptor
Type
Reference compound
Related Pathways
Membrane Transporter/Ion Channel
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology; Neurological Disease
Assay Protocol
https://www.medchemexpress.com/np-1815-px.html
Solubility
10 mM in DMSO
Smiles
O=C1NC2=C(N(C(C1)=O)C3=CC=CC(C4=NOC(N4)=S)=C3)C=CC5=C2C=CC=C5
Molecular Formula
C21H14N4O3S
Molecular Weight
402.43
References & Citations
[1]Matsumura Y, et al. A novel P2X4 receptor-selective antagonist produces anti-allodynic effect in a mouse model of herpetic pain. Sci Rep. 2016 Aug 31;6:32461.|[2]Obara K, et al. Effects of NP-1815-PX, a P2X4 Receptor Antagonist, on Contractions in Guinea Pig Tracheal and Bronchial Smooth Muscles. Biol Pharm Bull. 2022;45 (8) :1158-1165.|[3]D'Antongiovanni V, et al. Anti-inflammatory Effects of Novel P2X4 Receptor Antagonists, NC-2600 and NP-1815-PX, in a Murine Model of Colitis. Inflammation. 2022 Aug;45 (4) :1829-1847.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC040708-500 1x 500 µL
Kappa Light Chain (TB28-2), CF405S conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
LY438876 100 µg
GLT25D2 (COLGALT2) (NM_001303420) Human Over-expression Lysate
Sign In for Pricing
View Details 
BNC042923-500 1x 500 µL
Uroplakin 1A (Urothelial Differentiation Marker) (UPK1A/2923), CF405S conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
E-EL-M2432-01 24 Tests
Mouse FcεRII/CD23 (Receptor II for the Fc Region of Immunoglobulin E) ELISA Kit
Sign In for Pricing
View Details